{"altmetric_id":772558,"counts":{"readers":{"mendeley":27,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[51890],"posts_count":2},"news":{"unique_users_count":1,"unique_users":["multiple_sclerosis_discovery_forum"],"posts_count":1},"total":{"posts_count":27},"twitter":{"unique_users_count":11,"unique_users":["TheNeuroNetwork","MSMmeeting","neurodegirona","POSTECTRIMS","UNIEMGirona","Rene_Robles_C","mendibe_mar","fabiola1garcia","germanchique","NARCOMS","MoveOverMS"],"posts_count":24}},"selected_quotes":["Consulta todos los datos","La lactancia materna y las reca\u00eddas de esclerosis m\u00faltiple: un meta-an\u00e1lisis","latest...defended.eu\/m0712, #MSM16"],"citation":{"altmetric_jid":"4f6fa4f53cf058f610002e77","authors":["Julia Pakpoor","Giulio Disanto","Melanie V. Lacey","Kerstin Hellwig","Gavin Giovannoni","Sreeram V. Ramagopalan"],"doi":"10.1007\/s00415-012-6553-z","endpage":"2248","first_seen_on":"2012-06-01T14:15:30+00:00","funders":["mrc"],"isbns":[],"issns":["1432-1459","0340-5354"],"issue":"10","journal":"Journal of Neurology","last_mentioned_on":1489228202,"links":["http:\/\/www.springerlink.com\/content\/d237672375p4v1jl\/","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22619059","http:\/\/download.springer.com\/static\/pdf\/341\/art%253A10.1007%252Fs00415-012-6553-z.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00415-012-6553-z&token2=exp=1441433141~acl=%2Fstatic%2Fpdf%2F341%2Fart%25253A10.1007%25252Fs00415-012-6553-z.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1007%252Fs00415-012-6553-z*~hmac=4e3cf3bc154cb463d33ad1e53c224be30a346860948786de9699bd89d8e3b0ca","http:\/\/link.springer.com\/article\/10.1007%2Fs00415-012-6553-z","http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6553-z","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=22619059"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs00415-012-6553-z.pdf","pmid":"22619059","pubdate":"2012-01-01T00:00:00+00:00","publisher":"Springer-Verlag","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"startpage":"2246","subjects":["neurology"],"title":"Breastfeeding and multiple sclerosis relapses: a meta-analysis","type":"article","volume":"259","mendeley_url":"http:\/\/www.mendeley.com\/research\/breastfeeding-multiple-sclerosis-relapses-metaanalysis"},"altmetric_score":{"score":22.304,"score_history":{"1y":5.4,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":22.304},"context_for_score":{"all":{"total_number_of_other_articles":8342643,"mean":7.0366737244549,"rank":394714,"this_scored_higher_than_pct":95,"this_scored_higher_than":7947983,"rank_type":"exact","sample_size":8342643,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":95474,"mean":5.6210871974276,"rank":4038,"this_scored_higher_than_pct":95,"this_scored_higher_than":91435,"rank_type":"exact","sample_size":95474,"percentile":95},"this_journal":{"total_number_of_other_articles":1831,"mean":3.5473038251366,"rank":21,"this_scored_higher_than_pct":98,"this_scored_higher_than":1810,"rank_type":"exact","sample_size":1831,"percentile":98},"similar_age_this_journal_3m":{"total_number_of_other_articles":45,"mean":1.8318181818182,"rank":1,"this_scored_higher_than_pct":97,"this_scored_higher_than":44,"rank_type":"exact","sample_size":45,"percentile":97}}},"demographics":{"poster_types":{"member_of_the_public":9,"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":9,"Practitioners (doctors, other healthcare professionals)":1,"Scientists":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":2,"Student  > Doctoral Student":1,"Researcher":4,"Student  > Ph. D. Student":5,"Student  > Postgraduate":2,"Student  > Master":4,"Other":2,"Student  > Bachelor":2,"Professor":3},"by_discipline":{"Medicine and Dentistry":20,"Neuroscience":3,"Nursing and Health Professions":1,"Business, Management and Accounting":1,"Unspecified":2}}},"geo":{"twitter":{"AT":1,"ES":3,"VE":1},"mendeley":{"NL":1,"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/TheNeuroNetwork\/statuses\/208562356303822849","license":"datasift","citation_ids":[772558],"posted_on":"2012-06-01T14:15:15+00:00","author":{"name":"The NeuroNetwork","url":"http:\/\/www.springer.com\/neuroscience","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000761232861\/68866eaa87fb2dd844696f15cde82534_normal.jpeg","description":"Tweets from the publishing editors at Springer Neuroscience - latest articles, updates, conference tweets, news and more. \r\nSite notice: http:\/\/bit.ly\/11qCQpq","id_on_source":"TheNeuroNetwork","tweeter_id":"65467957","geo":{"lt":null,"ln":null},"followers":15739},"tweet_id":"208562356303822849"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/708307547393007616","license":"gnip","citation_ids":[1376742,772558],"posted_on":"2016-03-11T15:04:13+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"708307547393007616"},{"url":"http:\/\/twitter.com\/neurodegirona\/statuses\/708307921369763845","license":"gnip","rt":["MSMmeeting"],"citation_ids":[1376742,772558],"posted_on":"2016-03-11T15:05:42+00:00","author":{"name":"neurologiadegirona","image":"https:\/\/pbs.twimg.com\/profile_images\/650369832530092032\/Gc6u7b3i_normal.png","description":"Twitter del Servei de Neurologia de l'Hospital Dr. Josep Trueta de Girona","id_on_source":"neurodegirona","tweeter_id":"3854358687","geo":{"lt":null,"ln":null},"followers":47},"tweet_id":"708307921369763845"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/716580522948857857","license":"gnip","citation_ids":[772558],"posted_on":"2016-04-03T10:58:04+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"716580522948857857"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/724878296090042371","license":"gnip","citation_ids":[772558],"posted_on":"2016-04-26T08:30:28+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"724878296090042371"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/725637551181058048","license":"gnip","citation_ids":[772558],"posted_on":"2016-04-28T10:47:28+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"725637551181058048"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/727052519365451776","license":"gnip","citation_ids":[772558],"posted_on":"2016-05-02T08:30:03+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"727052519365451776"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/727811559733370880","license":"gnip","citation_ids":[772558],"posted_on":"2016-05-04T10:46:12+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"727811559733370880"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/737214482842193925","license":"gnip","citation_ids":[772558],"posted_on":"2016-05-30T09:30:04+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"737214482842193925"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/738060055874928645","license":"gnip","citation_ids":[772558],"posted_on":"2016-06-01T17:30:04+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"738060055874928645"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/739388802863501313","license":"gnip","citation_ids":[772558],"posted_on":"2016-06-05T09:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"739388802863501313"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/789737588361928705","license":"gnip","citation_ids":[4455237,12876496,772558,3802228],"posted_on":"2016-10-22T07:58:08+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"789737588361928705"},{"url":"http:\/\/twitter.com\/UNIEMGirona\/statuses\/789737805215850496","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[4455237,12876496,772558,3802228],"posted_on":"2016-10-22T07:59:00+00:00","author":{"name":"UNIEMTG","image":"https:\/\/pbs.twimg.com\/profile_images\/1506404908\/Nou_logo_versio__petita_normal.jpg","description":"Unitat de Neuroimmunologia i Esclerosi M\u00faltiple Territorial Girona","id_on_source":"UNIEMGirona","tweeter_id":"329846559","geo":{"lt":null,"ln":null},"followers":79},"tweet_id":"789737805215850496"},{"url":"http:\/\/twitter.com\/Rene_Robles_C\/statuses\/789737966935666688","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[4455237,12876496,772558,3802228],"posted_on":"2016-10-22T07:59:38+00:00","author":{"name":"Ren\u00e9 Robles Cede\u00f1o","image":"https:\/\/pbs.twimg.com\/profile_images\/2631452271\/8eec73f275b7653ac1bc2df51a74a87d_normal.png","description":"Neurologist. Associate professor. Computing-gadget lover. Amateur drummer.","id_on_source":"Rene_Robles_C","tweeter_id":"329085723","geo":{"lt":41.98311,"ln":2.82493,"country":"ES"},"followers":338},"tweet_id":"789737966935666688"},{"url":"http:\/\/twitter.com\/mendibe_mar\/statuses\/789741668681539584","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[4455237,12876496,772558,3802228],"posted_on":"2016-10-22T08:14:21+00:00","author":{"name":"Mar Mendibe","image":"https:\/\/pbs.twimg.com\/profile_images\/658956386248892416\/u80RMCFC_normal.jpg","description":"Neurologist. MS specialist. Lecturer in Faculty of Medicine. Interested in brain, MS, healthcare manegement. Bilbao lover.","id_on_source":"mendibe_mar","tweeter_id":"4051889169","geo":{"lt":43.26271,"ln":-2.92528,"country":"ES"},"followers":331},"tweet_id":"789741668681539584"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/799579444595851264","license":"gnip","citation_ids":[772558],"posted_on":"2016-11-18T11:46:09+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"799579444595851264"},{"url":"http:\/\/twitter.com\/mendibe_mar\/statuses\/799586118454964224","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[772558],"posted_on":"2016-11-18T12:12:40+00:00","author":{"name":"Mar Mendibe","image":"https:\/\/pbs.twimg.com\/profile_images\/658956386248892416\/u80RMCFC_normal.jpg","description":"Neurologist. MS specialist. Lecturer in Faculty of Medicine. Interested in brain, MS, healthcare manegement. Bilbao lover.","id_on_source":"mendibe_mar","tweeter_id":"4051889169","geo":{"lt":43.26271,"ln":-2.92528,"country":"ES"},"followers":331},"tweet_id":"799586118454964224"},{"url":"http:\/\/twitter.com\/fabiola1garcia\/statuses\/799607430921359360","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[772558],"posted_on":"2016-11-18T13:37:22+00:00","author":{"name":"Fabiola Garc\u00eda","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000656482690\/571bb3457df11ef15987403f424a7d5f_normal.jpeg","description":"Interested in Cognitive, Affective & Social Neurosciences.","id_on_source":"fabiola1garcia","tweeter_id":"304368171","geo":{"lt":null,"ln":null},"followers":437},"tweet_id":"799607430921359360"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/837007033392054272","license":"gnip","citation_ids":[772558],"posted_on":"2017-03-01T18:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"837007033392054272"},{"url":"http:\/\/twitter.com\/germanchique\/statuses\/837343974415347714","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[772558],"posted_on":"2017-03-02T16:48:55+00:00","author":{"name":"German Chique A.","image":"https:\/\/pbs.twimg.com\/profile_images\/748963891791757312\/4p7x5-9m_normal.jpg","description":"Neur\u00f3logo-Esclerosis M\u00faltiple y Enfermedades Desmielinizantes","id_on_source":"germanchique","tweeter_id":"129660045","geo":{"lt":10.48801,"ln":-66.87919,"country":"VE"},"followers":285},"tweet_id":"837343974415347714"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/837958302730420224","license":"gnip","citation_ids":[772558],"posted_on":"2017-03-04T09:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"837958302730420224"},{"url":"http:\/\/twitter.com\/NARCOMS\/statuses\/838016579078078464","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[772558],"posted_on":"2017-03-04T13:21:36+00:00","author":{"name":"NARCOMS","url":"http:\/\/www.narcoms.org","image":"https:\/\/pbs.twimg.com\/profile_images\/819560786804752385\/5Uk1b706_normal.jpg","description":"Nonprofit MS research registry & project of the Consortium of Multiple Sclerosis Centers. @NARCOMS follows MS care providers & clinics, no personal accounts.","id_on_source":"NARCOMS","tweeter_id":"1337589632","geo":{"lt":null,"ln":null},"followers":869},"tweet_id":"838016579078078464"},{"url":"http:\/\/twitter.com\/MoveOverMS\/statuses\/838016983543267328","license":"gnip","rt":["POSTECTRIMS"],"citation_ids":[772558],"posted_on":"2017-03-04T13:23:13+00:00","author":{"name":"Princess \ud83d\udc51","image":"https:\/\/pbs.twimg.com\/profile_images\/822546281679769602\/f8XAJ7Sa_normal.jpg","description":"Exploring health & wellness for better living & loving #MS #Dx2002 #MSActivist #Bohemian #goddess","id_on_source":"MoveOverMS","tweeter_id":"130572203","geo":{"lt":null,"ln":null},"followers":1543},"tweet_id":"838016983543267328"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/840510115182727168","license":"gnip","citation_ids":[772558],"posted_on":"2017-03-11T10:30:02+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"840510115182727168"}],"blogs":[{"title":"Does breastfeeding affect MS relapses?","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/2013\/10\/does-breastfeeding-affect-ms-relapses_8.html","citation_ids":[772558],"posted_on":"2013-10-08T23:30:00+00:00","summary":"MS typically onsets between 20-40 years of age and is more common in women than men. Coming to terms with the disease and its clinical manifestations will therefore often coincide with decisions of child-bearing facing young women.Relapse risk decreases du","author":{"name":"Multiple Sclerosis Research","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/","description":"A blog for people with MS and their families, by Barts and The London School of Medicine and Dentistry."}},{"title":"ClinicSpeak &amp; ResearchSpeak: breastfeeding reduces the risk of relapse","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/2015\/09\/clinicspeak-researchspeak-breastfeeding.html","license":"public","citation_ids":[4455237,772558],"posted_on":"2015-09-05T06:09:00+00:00","summary":"Can we now view breastfeeding as a DMT? #ClinicSpeak #ResearchSpeak #MSBlog #MSResearch\"The prospective study from the German MS and pregnancy register confirms that breastfeeding exclusively for a period of 2 months lowers your risk of having a relapse. W","author":{"name":"Multiple Sclerosis Research","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/","description":"A blog for people with MS and their families, by Barts and The London School of Medicine and Dentistry."}}],"news":[{"title":"MS Family Planning 201: Breastfeeding, DMTs, and the Risk of Postpartum Relapse","url":"http:\/\/www.msdiscovery.org\/news\/news_synthesis\/14212-ms-family-planning-201-breastfeeding-dmts-and-risk-postpartum-relapse","license":"public","citation_ids":[527724,1176082,2264152,1816158,21652197,21652199,2036537,21652206,21652210,1082602,3154817,21652219,1026327,21652228,21652231,690314,21652237,2249845,772558,21652239,21652240],"posted_on":"2014-10-06T15:01:31+00:00","summary":"The risk of relapse is higher in the postpartum period, but there are conflicting suggestions for women with MS about reducing this risk. Can exclusive breastfeeding alone prevent relapses? How soon after delivery should DMTs be reintroduced? Are any DMTs","author":{"name":"Multiple Sclerosis Discovery Forum","url":"http:\/\/www.msdiscovery.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/591\/normal\/Screen_Shot_2016-02-02_at_16.47.53.png?1454431685"}}]}}